title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Friday,20220506T160650,https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article,FGEN,0.005467,Neutral,0.044346
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,FGEN,0.00644,Neutral,0.040385
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - HealthEquity  ( NASDAQ:HQY ) ,20240604T095006,https://www.benzinga.com/news/24/06/39153820/why-healthequity-shares-are-trading-higher-here-are-20-stocks-moving-premarket,FGEN,0.127456,Somewhat-Bullish,0.173767
103 Biggest Movers From Yesterday,20220511T102237,https://www.benzinga.com/news/22/05/27130447/103-biggest-movers-from-yesterday,FGEN,0.042685,Neutral,0.081143
Aquestive  ( AQST )  Up as Anaphylm Pivotal Study Meets Goals,20240318T154700,https://www.zacks.com/stock/news/2242397/aquestive-aqst-up-as-anaphylm-pivotal-study-meets-goals,FGEN,0.271576,Neutral,-0.028975
"Stocks That Hit 52-Week Lows On Wednesday - Bristol-Myers Squibb Company Common Stock  ( NYSE:BMY ) , SenesTech, Inc. - Common Stock  ( NASDAQ:SNES ) ",20231004T160117,https://www.benzinga.com/markets/options/23/10/35092508/stocks-that-hit-52-week-lows-on-wednesday,FGEN,0.012708,Neutral,-0.07919
"Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - FibroGen  ( NASDAQ:FGEN ) , Aadi Bioscience  ( NASDAQ:AADI ) ",20230718T125413,https://www.benzinga.com/trading-ideas/long-ideas/23/07/33265738/top-5-health-care-stocks-which-could-rescue-your-portfolio-this-month,FGEN,0.228073,Bullish,0.470423
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,FGEN,0.041466,Neutral,-0.038518
